Navigation Links
Zithromax Arrhythmia Allegations Lawyer: Resource4thePeople Announces No-Cost Consultations Will be Available over the Holidays
Date:12/24/2013

San Diego, CA (PRWEB) December 24, 2013

http://www.resource4thepeople.com/defectivedrugs/Zithromax-lawsuits.html

Resource4thePeople announced today that its national network of attorneys will be available over the upcoming holiday season to consumers inquiring about legal options in connection with allegations involving life-threatening side effects from Zithromax and other azithromycin-based antibiotics.

The U.S. Food and Drug Administration identified these dangerous side effects, including arrhythmia and sudden death in a March 3, 2013 Health Warning* issued to health care professionals and consumers.

“We are proud to announce that our policy of providing complimentary consultations to consumers inquiring about these allegations and their legal options to seek compensation will not be interrupted by the holiday season,” said Resource4thePeople.

"In response to numerous inquiries from consumers who have asked about whether our attorneys will be available over the holidays we are announcing that our 24-hour hotline will be staffed for those who may be seeking legal options about their eligibility to seek compensation over these allegations."

Resource4thePeople said that the health warning issued by the FDA has been generating increasing numbers of inquiries from consumers who may have been affected by these allegations and are requesting information about how to seek compensation for medical and other expenses.

The FDA describes Zithromax as a macrolide antibiotic used in the treatment of bacterial infections in many parts of the body and expresssed these concerns in the March 3, 2013 Health Warning* issued by the FDA addressed similar concerns:

"The U.S. Food and Drug Administration (FDA) is warning the public that azithromycin (Zithromax or Zmax) can cause abnormal changes in the electrical activity of the heart that may lead to a potentially fatal irregular heart rhythm. Patients at particular risk for developing this condition include those with known risk factors such as existing QT interval prolongation, low blood levels of potassium or magnesium, a slower than normal heart rate, or use of certain drugs used to treat abnormal heart rhythms, or arrhythmias. This communication is a result of our review of a study by medical researchers as well as another study by a manufacturer of the drug that assessed the potential for azithromycin to cause abnormal changes in the electrical activity of the heart."

To aid consumers, Resource4thePeople's national network of attorneys are reviewing claims that involve possible symptoms of arrhythmia, sudden death and other serious health allegations involving popular antibiotics such as Zithromax.

The medications involved are known generically as azithromycin, and are sold under names such as Zithromax, Zithromax Z-Pak, Zithromax Tri-Pak and Zmax.

The following are among health symptoms being reviewed by Resource4thePeople's national network of attorneys:

    fast, pounding, or irregular heart beat
    dizziness
    fainting
    rash
    hives
    itching
    wheezing or difficulty breathing or swallowing
    swelling of the face, throat, tongue, lips, eyes, hands, feet, ankles, or lower legs
    hoarseness
    mouth sores
    severe diarrhea (watery or bloody stools) that may occur with or without fever and stomach cramps (may occur up to 2 months or more after your treatment)
    yellowing of the skin or eyes
    extreme tiredness
    unusual bleeding or bruising
    lack of energy
    loss of appetite
    pain in the upper right part of the stomach
    flu-like symptoms
    dark-colored urine
    blisters or peeling of the skin
    unusual muscle weakness or difficulty with muscle control

The Canadian equivalent of the FDA, Health Canada, also issued a warning about Zithromax that was posted May 16, 2013.** It warned that "Prolonged cardiac repolarization and QT interval have been seen in treatment with macrolides including azithromycin. Health care practitioners should consider the risk of fatal cardiac arrhythmias with azithromycin when prescribing antibacterial treatment for patients who are already at risk for cardiovascular events."

The FDA also sent a strongly worded warning letter*** on June 19, 2012 to the medications' manufacturer, Pfizer Inc., over language federal officials described as "false" and "misleading" in a marketing brochure.

In its letter the FDA criticized a brochure issued by Pfizer for the medications and made the following finding:

"The brochure is false or misleading because it omits and minimizes important risk information, makes unsubstantiated superiority claims, omits material facts, broadens the indication for the drug product, makes misleading efficacy claims, and makes unsubstantiated claims for Zmax."

FDA regulators also found that the brochure omitted important information that should have warned consumers about the risk of serious heart problems:

"Specifically, the brochure omits the important risk of QT prolongation associated with Zmax use. The WARNINGS AND PRECAUTIONS section of the PI states, “[p]rolonged cardiac repolarization and QT interval, imparting a risk of developing cardiac arrhythmia and torsades de pointes, have been seen in treatment with other macrolides. A similar effect with azithromycin cannot be completely ruled out in patients at increased risk for prolonged cardiac repolarization” (emphasis in original). By omitting this serious risk associated with Zmax, the brochure misleadingly suggests that the drug is safer than has been demonstrated."

SOURCES:
*http://www.fda.gov/drugs/drugsafety/ucm341822.htm
**http://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2013/29199a-eng.php
***http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/EnforcementActivitiesbyFDA/WarningLettersandNoticeofViolationLetterstoPharmaceuticalCompanies/UCM310527

Read the full story at http://www.prweb.com/releases/2013/12/prweb11443803.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. D'Oliveira & Associates Now Offers a No Win No Fee Promise in Zithromax Cases
2. Zithromax Arrhythmia and Sudden Death Allegation Lawsuits Now Being Investigated by Resource4thePeople Lawyers
3. Zithromax Arrhythmia and Sudden Death Allegation Claims Now Being Accepted by Resource4thePeople Lawyers
4. Rottenstein Law Group Notes Medical Journal Article Advising Doctors To Use Caution When Prescribing Zithromax and Other Antibiotics
5. 2013 Alleged Zithromax Arrhythmia and Sudden Death Cases Update: Canadian Health Officials Issue Warning
6. Rottenstein Law Group LLP Announces Launch of Zithromax Lawsuit Center
7. Zithromax Arrhythmia and Sudden Death Cases Allegations Update: Resource4thePeople Reports FDA Issued Warning Letter to Manufacturer over False and Misleading Information
8. Zithromax Antibiotics Arrhythmia Lawsuits Help: Resource4thePeople Urges Consumers to Review Dangerous Side Effects Outlined by Medical Experts
9. Fine tuning cardiac ablation could lead to quicker results for patients with arrhythmias
10. ESC analysis reveals arrhythmia treatment gaps between Eastern and Western Europe
11. Predicting risk of arrhythmias and sudden cardiac death: Theres a computer model for that
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2017)... ... January 23, 2017 , ... Valentine’s Day is a time when many people celebrate romance ... those who may be looking for the ideal present, Atlanta-based Perimeter Plastic Surgery ... additional $25 free. Or, spend $200 and get $50 free. , “A lot of ...
(Date:1/22/2017)... SAINT- MALO, FRANCE (PRWEB) , ... January 22, 2017 , ... ... the Indian Ocean, isolated from the rest of the world with ZANZIBAR MILKY CREAM. ... Africa, Phytocéane used key ingredients like Virgin Coconut Oil and moisturizing vegetal coral to ...
(Date:1/22/2017)... ... January 22, 2017 , ... Zifam Pinnacle, an Australian ... world, recently met with big-name retail buyers at the January ECRM Trade Show in ... and uses the utmost safety standards in all of its creations to help create ...
(Date:1/22/2017)... ... January 22, 2017 , ... "Photo Cloud allows FCPX users to add ... slideshow with complete ease," said Christina Austin - CEO of Pixel Film Studios. ... FCPX timeline. Presets include scenes with one, three, four or five focus ...
(Date:1/22/2017)... ... , ... Medical lab testing through hospitals and other traditional methods ... will take days to arrive to the end customer, having to travel through medical ... lab tests, bypassing the cost and delay of traditional means. Now all employees of ...
Breaking Medicine News(10 mins):
(Date:1/23/2017)... InDex Pharmaceuticals Holding AB (publ) today announced ... of the European Crohn,s and Colitis Organisation (ECCO). The ECCO congress ... on inflammatory bowel disease (IBD). The congress is held in ... ... again having been selected to present data at the largest IBD ...
(Date:1/23/2017)... 23, 2017 Just two weeks remain until legal experts and ... in Central London to discuss the flow of ... the market, Parallel Trade 2017 . In the run ... attendees which is available to read in the event download centre ... Some of those ...
(Date:1/22/2017)... ABU DHABI , Saudi Arabia , January ... the US and UAE ... of the Future , at the World Economic Forum   ... future will be driven by big data and powered by artificial intelligence and ... of experts that discussed the ,Hospital of the Future, at the concluding day ...
Breaking Medicine Technology: